RhumbLine Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.49M Buy
285,621
+14,187
+5% +$124K ﹤0.01% 1772
2025
Q1
$2.16M Sell
271,434
-9,986
-4% -$79.5K ﹤0.01% 1776
2024
Q4
$2.56M Buy
281,420
+5,018
+2% +$45.6K ﹤0.01% 1756
2024
Q3
$2.54M Sell
276,402
-133
-0% -$1.22K ﹤0.01% 1777
2024
Q2
$2.7M Buy
276,535
+106,770
+63% +$1.04M ﹤0.01% 1722
2024
Q1
$2.56M Sell
169,765
-21,740
-11% -$328K ﹤0.01% 1781
2023
Q4
$4.13M Buy
191,505
+540
+0.3% +$11.6K ﹤0.01% 1538
2023
Q3
$3.55M Sell
190,965
-2,318
-1% -$43.1K ﹤0.01% 1537
2023
Q2
$4.89M Buy
193,283
+7,063
+4% +$179K 0.01% 1387
2023
Q1
$4.82M Sell
186,220
-1,107
-0.6% -$28.7K 0.01% 1336
2022
Q4
$4.43M Buy
187,327
+10,839
+6% +$256K 0.01% 1347
2022
Q3
$4.47M Buy
176,488
+18,919
+12% +$480K 0.01% 1299
2022
Q2
$5.23M Buy
157,569
+26,653
+20% +$885K 0.01% 1217
2022
Q1
$9.44M Buy
130,916
+2,921
+2% +$211K 0.01% 979
2021
Q4
$11.8M Buy
127,995
+3,565
+3% +$327K 0.01% 901
2021
Q3
$15.8M Sell
124,430
-10,639
-8% -$1.35M 0.02% 714
2021
Q2
$22.5M Buy
135,069
+17,135
+15% +$2.85M 0.03% 543
2021
Q1
$21.4M Buy
117,934
+1,379
+1% +$251K 0.03% 551
2020
Q4
$23.3M Buy
116,555
+34,169
+41% +$6.83M 0.03% 481
2020
Q3
$18.1M Sell
82,386
-5,304
-6% -$1.16M 0.03% 508
2020
Q2
$16.7M Sell
87,690
-18,023
-17% -$3.44M 0.03% 533
2020
Q1
$16.4M Buy
105,713
+2,616
+3% +$406K 0.03% 453
2019
Q4
$8.63M Buy
103,097
+6,705
+7% +$561K 0.01% 919
2019
Q3
$6.53M Sell
96,392
-3,438
-3% -$233K 0.01% 1040
2019
Q2
$6.63M Buy
99,830
+11,072
+12% +$735K 0.01% 1036
2019
Q1
$4.94M Sell
88,758
-1,101
-1% -$61.2K 0.01% 1187
2018
Q4
$4.45M Buy
89,859
+29,905
+50% +$1.48M 0.01% 1177
2018
Q3
$5.18M Buy
59,954
+244
+0.4% +$21.1K 0.01% 1085
2018
Q2
$3.47M Buy
59,710
+6,094
+11% +$354K 0.01% 1346
2018
Q1
$2.16M Buy
53,616
+2,065
+4% +$83.2K ﹤0.01% 1564
2017
Q4
$1.8M Sell
51,551
-9,404
-15% -$328K ﹤0.01% 1685
2017
Q3
$2.02M Buy
60,955
+1,025
+2% +$34K ﹤0.01% 1622
2017
Q2
$2.08M Buy
59,930
+35,120
+142% +$1.22M ﹤0.01% 1557
2017
Q1
$620K Buy
24,810
+3,653
+17% +$91.3K ﹤0.01% 2158
2016
Q4
$349K Buy
21,157
+3,927
+23% +$64.8K ﹤0.01% 2416
2016
Q3
$315K Buy
17,230
+500
+3% +$9.14K ﹤0.01% 2458
2016
Q2
$268K Buy
+16,730
New +$268K ﹤0.01% 2594